Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dymedso is a private Canadian medical device company focused on respiratory care and airway clearance therapy. The company develops and markets the Frequencer, a non-invasive electro-acoustical device that uses low-frequency sound waves to induce chest wall vibrations and promote bronchial drainage. Its technology is used as a component of chest physiotherapy for patients with impaired mucociliary clearance, including cystic fibrosis and other chronic respiratory disorders. Dymedso positions its core value proposition around gentler, acoustics-based airway clearance compared with conventional percussion methods. The company appears to operate commercially as a small, active medical technology business rather than as a drug-development biotech company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dymedso.